dna test no longer on ofa - Page 4

Pedigree Database

Premium classified

This is a placeholder text
Group text

Premium classified

This is a placeholder text
Group text

Premium classified

This is a placeholder text
Group text

Premium classified

This is a placeholder text
Group text

by vk4gsd on 16 April 2016 - 22:04

Why is it the public accept mining companies get exclusive rights to plunder gold and oil they discover but have a different standard for genes. They are both commodities.

by joanro on 16 April 2016 - 22:04

Vk, this issue here is that the test is a bogus. Read the op, if you haven't, it seem you have not by your comment. No one is complaining about the cost of DNA testing, if the test is legitimate.
Another difference with dogenes, is that they required payment up front, for the cotton swabs. Other labs doing DNA, sent the test kit, the payment is sent in with the completed kit. This fly bynite refused to return my $900.00 dollars for 9 unused cotton swabs...plus, the supposed rd test is the one and only DNA test this lab does.


by vk4gsd on 16 April 2016 - 23:04

Ah, this is what happens when the peer review process is compromised by private science. This is the future of an unregulated for profit world the US is so mad about forcing on the universe.

by joanro on 16 April 2016 - 23:04

Not the US in general, just the republican extremists.

But this lab is in ont, canada.


bubbabooboo

by bubbabooboo on 17 April 2016 - 02:04

The SCOTUS ruling does not prevent Myriad Genetics or Dogenes from selling their tests .. it does however keep companies such as Myriad or Dogenes from claiming exclusive rights to testing for a particular gene or preventing others from doing research on the effects of treatments or other scientific inquiry into the gene.  Once Myriad Genetics lost their case in the SCOTUS the test for BRCA was offered by other companies, the price for BRCA testing plummeted, and researchers were free to do research on that gene.  However the regulation of who can offer testing for BRCA and how the results are reported and interpreted is poor.  Some companies interpret some deviations from normal in the BRCA gene as being a cancer risk while others report the same findings as inconclusive and not a concern.  Companies can develop a test and with very flimsy evidence and in some cases poor results in terms of accuracy or precision of the test for predicting risks sell the tests to the public.  The only gate keepers to call out the fakes and money chasers are the geneticists and genetic researchers through peer review and refusal to offer or use some companies tests or results in hospitals.  The government at both Federal and State levels has done little to regulate genetic testing.  As usual the licensing and qualifications of the geneticists and professionals serving the patients is regulated more than those developing or selling products to the public.






 


Contact information  Disclaimer  Privacy Statement  Copyright Information  Terms of Service  Cookie policy  ↑ Back to top